Dehydroemetine general information: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Dehydroemetine}} {{CMG}} <ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: P...")
 
mNo edit summary
Line 5: Line 5:




<ref>{{Cite web  | last =  | first =  | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher =  | date =  | accessdate = 31 December 2013 }}</ref>
<ref>{{Cite web  | last =  | first =  | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.3.html#Jh2922e.2.1.3 | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Revision as of 00:31, 31 December 2013

Dehydroemetine
MEBADIN® Prescribing Information
General Information
Clinical Information
Dosage and Administration
Precautions
Use in Pregnancy
Adverse Effects
Drug Interactions
Storage

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


[1]

References

  1. "WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: Amoebiasis and giardiasis: Dehydroemetine".